Herold Advisors’s Hologic HOLX Stock Holding History

Herold Advisors’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,200	Closed	-$88K	–	374
2021 Q3	$88K	Buy	+1,200	New	+$90K	0.03%	295

Other funds holding HOLX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Herold Advisors's HOLX Position: Q4 2021 in Review

Herold Advisors sold out of Hologic (HOLX) in Q4 2021, closing a stake of 1,200 shares — an estimated $88K sold.

Herold Advisors first reported a position in HOLX in Q3 2021 and held it in 1 quarter. The position peaked at $88K in Q3 2021. 678 funds tracked by Wall St. Rank hold HOLX as of Q4 2021.

Herold Advisors reported no remaining Hologic position as of Q4 2021 after selling out during the quarter.
Herold Advisors sold 1,200 Hologic shares in Q4 2021, an estimated $88K.
Herold Advisors first reported a position in Hologic in Q3 2021 and held it in 1 quarter.
Herold Advisors's Hologic position peaked at $88K in Q3 2021.
678 funds tracked by Wall St. Rank held Hologic as of Q4 2021.

Based on Herold Advisors's 13F filing for Q4 2021, filed 20 Jan 2022.